All Stories

  1. Multi-Targeted Anticancer Agents

    Article • Current Topics in Medicinal Chemistry, November 2017, Bentham Science Publishers

    Dr Fuyi Wang

  2. Dual-targeting organometallic ruthenium(ii) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands

    Article • Dalton Transactions, January 2015, Royal Society of Chemistry

    Dr Fuyi Wang

  3. Discovery of a dual-targeting organometallic ruthenium complex with high activity inducing early stage apoptosis of cancer cells

    Article • Metallomics, January 2015, Oxford University Press (OUP)

    Dr Fuyi Wang

  4. Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes

    Article • Metallomics, January 2014, Oxford University Press (OUP)

    Dr Fuyi Wang

  5. Identification and discrimination of binding sites of an organoruthenium anticancer complex to single-stranded oligonucleotides by mass spectrometry

    Article • The Analyst, January 2014, Royal Society of Chemistry

    Dr Fuyi Wang

  6. Copper binding promotes the interaction of cisplatin with human copper chaperone Atox1

    Article • Chemical Communications, January 2013, Royal Society of Chemistry

    Dr Fuyi Wang

  7. Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis

    Article • Chemical Communications, January 2013, Royal Society of Chemistry

    Dr Fuyi Wang